Document is current
Any future updates will be listed below
-
Authors
Beitzen-Heineke, Antonia
Wise, David R.
Berger, Jeffrey S.
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft
National Heart, Lung, and Blood Institute (R35 HL144993)
- License Information
-
More Information
Article History
Received: 9 July 2024
Accepted: 23 October 2024
First Online: 5 December 2024
Declarations
:
: Not applicable.
: Not applicable.
: D.R.W. is a paid consultant for Leap Therapeutics, Pfizer, Sanofi, Myovant, Bayer, AstraZeneca, Accutar, K36, Oncoc4. He has received travel funding from Pfizer and Bayer. A.B. and J.S.B. declare that they have no conflicts of interest that are relevant to the content of this article.
